Institutional Ownership Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN). We have compiled data on the 152 institutions that hold shares in the stock, with a total of 90.3 Million shares, which have been reported (via 13F filing form) to have a value of $2.03 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
8,127,100
shares
|
$183 Million
3.76% of portfolio
|
Q3 2025
Reduced 0.49%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
7,589,095
shares
|
$171 Million
0.0% of portfolio
|
Q3 2025
Added 4.63%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
7,562,971
shares
|
$170 Million
1.96% of portfolio
|
Q3 2024
Reduced 0.74%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
7,495,000
shares
|
$168 Million
1.8% of portfolio
|
Q2 2025
Added 34.4%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
6,895,746
shares
|
$155 Million
8.33% of portfolio
|
Q3 2024
Added 11.53%
|
|
|
Commodore Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
5,700,000
shares
|
$128 Million
2.77% of portfolio
|
Q3 2025
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
4,559,917
shares
|
$103 Million
0.0% of portfolio
|
Q3 2025
Added 5.89%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,120,508
shares
|
$92.6 Million
0.0% of portfolio
|
Q2 2024
Added 24.28%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
3,939,000
shares
|
$88.5 Million
0.05% of portfolio
|
Q3 2025
Added 207.73%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
2,633,918
shares
|
$59.2 Million
0.0% of portfolio
|
Q4 2024
Added 30.59%
|
|
|
Candriam S.C.A.
|
Nov 05, 2025 Q3 2025 |
2,368,235
shares
|
$53.2 Million
0.1% of portfolio
|
Q2 2025
Added 9.95%
|
|
|
Acorn Capital Advisors, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,971,264
shares
|
$44.3 Million
7.52% of portfolio
|
Q4 2024
New holding
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,891,925
shares
|
$42.5 Million
0.09% of portfolio
|
Q3 2025
Reduced 37.97%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,714,552
shares
|
$38.5 Million
0.0% of portfolio
|
Q3 2025
Added 4.97%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,605,693
shares
|
$36.1 Million
0.0% of portfolio
|
Q3 2025
Added 16.91%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
1,589,334
shares
|
$35.7 Million
0.0% of portfolio
|
Q3 2025
Reduced 59.24%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
1,473,371
shares
|
$33.1 Million
0.0% of portfolio
|
Q3 2025
Added 24.81%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
1,456,401
shares
|
$32.7 Million
0.0% of portfolio
|
Q3 2025
Reduced 11.78%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
1,277,463
shares
|
$28.7 Million
0.0% of portfolio
|
Q3 2025
Added 0.01%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 18, 2025 Q3 2025 |
1,104,204
shares
|
$24.8 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
972,772
shares
|
$21.9 Million
0.0% of portfolio
|
Q3 2025
Reduced 16.97%
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2025 Q3 2025 |
950,000
shares
|
$21.4 Million
0.55% of portfolio
|
Q3 2025
Added 35.71%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
941,584
shares
|
$21.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 5.54%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
934,760
shares
|
$21 Million
0.89% of portfolio
|
Q3 2025
Added 14.3%
|
|
|
Superstring Capital Management LP
New York, NY |
Nov 14, 2025 Q3 2025 |
789,646
shares
|
$17.8 Million
5.84% of portfolio
|
Q3 2025
Reduced 38.63%
|
|